mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells

Published:2015-10 Issue:1 Volume:367 Page:76-87
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Karthik Govindasamy-Muralidharan,Ma Ran,Lövrot John,Kis Lorand Levente,Lindh Claes,Blomquist Lennart,Fredriksson Irma,Bergh Jonas,Hartman Johan

Funder

Swedish Society for Medical Research

Radiumhemmet

Cancerfonden

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference73 articles.

1. Influence of sex hormones on cancer progression;Folkerd;J. Clin. Oncol,2010

2. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers;Nadji;Am. J. Clin. Pathol,2005

3. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Davies;Lancet,2011

4. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial;Powles;J. Natl Cancer Inst,2007

5. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Phillips;J. Clin. Oncol,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reciprocal Relationship Between Cancer Stem Cells and Myeloid-Derived Suppressor Cells: Implications for Tumor Progression and Therapeutic Strategies;Future Oncology;2024-02

2. mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers;Breast Cancer Research;2023-10-30

3. mTOR signalling pathway in stem cell bioactivities and angiogenesis potential;Cell Proliferation;2023-05-08

4. Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group;Molecular Oncology;2022-12-07

5. Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies;Cancers;2022-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3